AMAranza Meza-Dorantes

Aranza Meza-Dorantes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aranza Meza-Dorantes has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nuclear Lamina Dysfunction and DNA Damage as Drivers of Premature Senescence in a Human Müller Glial Cell Model of Spinocerebellar Ataxia Type 7

    by Vanessa Ruiz-Esparza-Palacios, Ian García-Aguirre, Guadalupe E. Jiménez-Gutiérrez, Nadia M. Murillo-Melo, Aranza Meza-Dorantes, Yessica S. Tapia-Guerrero, Oscar Pérez-Méndez, Jose M. Gonzalez-Meljem, Bulmaro Cisneros, Jonathan J. Magaña

    Spinocerebellar ataxia type 7 (SCA7) is a hereditary disorder characterized by degeneration of the cerebellum and retina. SCA7 is caused by the expansion of a polyQ tract in the ATXN7 gene, leading to protein misfolding, transcriptional dysregulation, and neuronal/glial degeneration. Recently, altered DNA damage response (DDR) was revealed in SCA7, which may contribute to disease pathogenesis. Impaired DDR causes DNA damage, which in turn triggers cellular senescence. Consistently, senescent cells were identified in the cerebellum Purkinje layer of an SCA7 mouse model. In this study a Müller glial model (MIO-M1) expressing normal (10Q) or expanded (64Q) ataxin-7 was utilized to ascertain whether mutant protein induces genomic instability and consequently the emergence of senescence. PolyQ ataxin-7 elicits nuclear lamina disorganization, γH2AX foci (DDR marker), micronuclei and telomere shortening, which indicate genomic instability. Furthermore, 64Q cells expressing polyQ ataxin-7 exhibited senescence hallmarks, including heterochromatin loss and increased senescence-associated β-galactosidase activity, but not p21 nor p53 expression. Instead of the senescence-associated enlargement of nucleoli, these cells exhibited nucleolar disaggregation. Together, these findings indicate that the expression of polyQ ataxin-7 disrupts the nuclear architecture, thereby inducing genomic instability. This, in turn, results in a senescence-like phenotype, a phenomenon that may contribute to glial pathogenesis.

  • Open Access

    Integrated Plasma and Glial Cell Evidence Indicates a Functional Role for hsa-miR-342-5p in Spinocerebellar Ataxia Type 7 and Its Potential Use as a Biomarker

    by Verónica M. Borgonio-Cuadra, Aranza Meza-Dorantes, José Manuel Rodríguez-Pérez, Ian A. García-Aguirre, Nadia Mireya Murillo-Melo, Nonanzit Pérez-Hernández, Oscar Hernández-Hernández, Marcela Hernández-Ortega, Zazil Herrera-Carrillo, Bulmaro Cisneros, et al.

    Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disease characterized by cerebellar ataxia and retinal degeneration, caused by an abnormal expansion of CAG repeats at the ATXN7 gene. Disease onset and progression vary among patients, underscoring the need for novel tools to improve disease monitoring. Circulating miRNAs represent a promising prognostic tool, due to their minimally invasive sampling and high stability. The aim of this study was to assess the expression of twelve circulating miRNAs associated with neurodegeneration in plasma samples from SCA7 patients and in an inducible SCA7 glial cell model. A comparison of SCA7 patients and controls revealed that nine miRNAs exhibited significantly higher expression. Furthermore, comparison of patients with different SCA7 phenotypes to controls revealed that most miRNAs were overexpressed in plasma from early-onset patients corresponding to the clinically more severe phenotype. Regarding the cell model, we identified three miRNAs that were dysregulated; however, only hsa-miR-342-5p displayed a pattern consistent with that observed in the plasma of patient. Our findings indicate that hsa-miR-342-5p is differentially expressed in the plasma of patients and the SCA7 cellular model, implying that it can serve as a biomarker and facilitate the identification of novel processes involved in SCA7.


  • Open Access

    In Silico Analysis of miRNA-Regulated Pathways in Spinocerebellar Ataxia Type 7

    by Verónica Marusa Borgonio-Cuadra, Aranza Meza-Dorantes, Nonanzit Pérez-Hernández, José Manuel Rodríguez-Pérez, Jonathan J. Magaña

    Spinocerebellar ataxia type 7 (SCA7) is an inherited neurodegenerative disease characterized by cerebellar ataxia and retinal degeneration, caused by an abnormal expansion of the CAG trinucleotide in the coding region of the ATXN7 gene. Currently, in silico analysis is used to explore mechanisms and biological processes through bioinformatics predictions in various neurodegenerative diseases. Therefore, the aim of this study was to identify candidate human gene targets of four miRNAs (hsa-miR-29a-3p, hsa-miR-132-3p, hsa-miR-25-3p, and hsa-miR-92a-3p) involved in pathways that could play an important role in SCA7 pathogenesis through comprehensive in silico analysis including the prediction of miRNA target genes, Gen Ontology enrichment, identification of core genes in KEGG pathways, transcription factors and validated miRNA target genes with the mouse SCA7 transcriptome data. Our results showed the participation of the following pathways: adherens junction, focal adhesion, neurotrophin signaling, endoplasmic reticulum processing, actin cytoskeleton regulation, RNA transport, and apoptosis and dopaminergic synapse. In conclusion, unlike previous studies, we highlight using a bioinformatics approach the core genes and transcription factors involved in the different biological pathways and which ones are targets for the four miRNAs, which, in addition to being associated with neurodegenerative diseases, are also de-regulated in the plasma of patients with SCA7.


  • Open Access

    Current Overview of Spinocerebellar Ataxia Type 7 in Mexican Population: Challenges in Specialized Care for a Rare Disease

    by César M. Cerecedo-Zapata, Yessica S. Tapia-Guerrero, José A. Ramírez-González, Aranza Meza-Dorantes, Karla N. Tercero-Pérez, Hernán Cortés, Araceli Guerra-Grajeda, Ilse H. Ortega-Ibarra, Gabriela Gatica-Ramos, Alfredo Poblete-Velazquez, et al.

    Spinocerebellar ataxia type 7 (SCA7) is a rare genetic disease characterized by progressive cerebellar syndrome and macular degeneration. In a previous study, we clinically and genetically characterized a group of Mexican patients, which represented one of the largest cohorts of SCA7 patients worldwide and demonstrated that all patients had a unique genetic origin. Our laboratory developed a program for the diagnosis, medical care, and long-term follow-up of these patients living in Veracruz State, and in this report, we present an update to this research, covering 2013 to 2024. So far, we identified 172 SCA7 carriers, with a few cases outside Veracruz, and our data support that the length of the CAG repeat tract mainly determines disease severity and life expectancy, and accordingly, we define three different phenotypes, early-onset (EO), classical-onset (CO), and late-onset (LO), with EO patients showing the lowest life expectancy. Furthermore, we found that parental transmission of mutant alleles leads to increased CAG repeat instability, compared to maternal ones. Interestingly, a haplotype analysis revealed that patients outside Veracruz may have different genetic origins. In conclusion, longitudinal observations of SCA7 patients provide insight into the natural history of SCA7 and help to design strategies for diagnosis, genetic counseling, physical rehabilitation, and therapeutic alternatives.